PTK2 and breast carcinoma: Recent studies have identified HER2, a prognostic marker for aggressiveness in breast cancer, to influence the migratory behavior of breast cancer cells in vitro through a novel signaling pathway involving phosphorylation of FAK at tyrosine 861 by its upstream kinase c-Src [18,19].